FDA Watch: DOGE Changes at FDA Upend Approval Processes, Observers Say
Pre-submission and Q-Submission meetings apparently have been halted, for now
Pre-submission and Q-Submission meetings apparently have been halted, for now
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Experts Nathan Buchbinder and Julianna Ianni discuss digital pathology and AI trends in 2024—and what the next year may hold
Although the timelines have been extended several times, IVDR complexity has created a concerning bottleneck in the approval process
Recent False Claims Act settlements underscore the government’s emphasis on individual accountability in healthcare fraud matters
The potential occupational safety pros and cons of artificial intelligence implementation into the clinical lab
How labs can better use their valuable data and highlight that data’s benefits to the health systems they serve
What lab safety violations are most common? What happens when lab safety is overlooked? And how can your lab avoid becoming a statistic?
A solid health and safety plan in the lab not only meets regulatory requirements, but also fosters a secure environment for staff
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
With strikes increasing across industries, what happens if workers involved in the ancillary services labs depend on go on strike?